Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Inventory-to-Revenue : 2.53 (As of Mar. 2024)

Hunan Er-Kang Pharmaceutical Co Inventory-to-Revenue Chart

Hunan Er-Kang Pharmaceutical Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Inventory-to-Revenue		Get a 7-Day Free Trial					0.31	0.33	0.33	0.41	0.42

Hunan Er-Kang Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventory-to-Revenue	Get a 7-Day Free Trial															1.53	1.67	1.98	2.11	2.53

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue falls into.

Hunan Er-Kang Pharmaceutical Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Er-Kang Pharmaceutical Co  (SZSE:300267) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hunan Er-Kang Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2024 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hunan Er-Kang Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Er-Kang Pharmaceutical Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description